Thursday, 5 November 2026
M
Meridian Globe
Live briefing

[Comment] Deucrictibant: a novel oral on-demand treatment for hereditary angioedema

Source 柳叶刀 Lancet27d ago
Summary

Hereditary angioedema due to a deficiency of C1 inhibitor (HAE-C1INH) is clinically characterised by recurrent, generally unpredictable attacks of angioedema.1…

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
United Kingdom
Language
English
Item ID
health-a8e094e9

Comments 0 comments

No comments yet. Be the first.

[Comment] Deucrictibant: a novel oral on-demand treatment for hereditary angioedema · Meridian Globe